We are live on
!
Find out more
PAM
Panagora Asset Management Portfolio holdings
AUM
$32.6B
1-Year Est. Return
52.29%
This Fund
S&P 500
This Quarter
Est. Return
+15.1%
1 Year Est. Return
+52.29%
3 Year Est. Return
+171.1%
5 Year Est. Return
+242.78%
10 Year Est. Return
+962.16%
AUM
$22.5B
AUM Growth
+$1.01B
(+4.7%)
Cap. Flow
-$1.78B
Cap. Flow
% of AUM
-7.91%
Top 10 Holdings %
Top 10 Hldgs %
17.81%
Holding
2,706
New
231
Increased
769
Reduced
968
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$136M |
| 2 |
Incyte
INCY
|
+$93.7M |
| 3 |
Sherwin-Williams
SHW
|
+$78.1M |
| 4 |
Parker-Hannifin
PH
|
+$77.1M |
| 5 |
Medtronic
MDT
|
+$70.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$145M |
| 2 |
Amgen
AMGN
|
+$136M |
| 3 |
Prologis
PLD
|
+$128M |
| 4 |
Adobe
ADBE
|
+$121M |
| 5 |
Humana
HUM
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.07% |
| 2 | Financials | 16.28% |
| 3 | Healthcare | 12.58% |
| 4 | Consumer Discretionary | 11.23% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
China Pharma Holdings
CPHI
$45.8M
| $35K | ﹤0.01% |
208
+25
| +14% | +$3.68K |
|
2127
Espey Mfg & Electronics Corp
ESP
$187M
| $35K | ﹤0.01% |
1,416
+39
| +3% | +$974 |
|
2128
InspireMD
NSPR
$34.7M
| $35K | ﹤0.01% |
334
+192
| +135% | +$24.8K |
|
2129
Ocugen
OCGN
$434M
| $35K | ﹤0.01% |
5,078
+4,485
| +756% | +$38.3K |
|
2130
OP Bancorp
OPBK
$233M
| $35K | ﹤0.01% |
+4,041
| New | +$36.7K |
|
2131
PRA Group
PRAA
$755M
| $35K | ﹤0.01% |
1,300
| – | – |
|
2132
Travelzoo
TZOO
$75.4M
| $35K | ﹤0.01% |
2,588
+2,570
| +14,278% | +$34.1K |
|
|
ALACR
2133
DELISTED
Alberton Acquisition Corp Rights
ALACR
| $35K | ﹤0.01% |
+205,374
| New | +$39.2K |
|
|
MSBF
2134
DELISTED
MSB Financial Corp.
MSBF
| $35K | ﹤0.01% |
1,926
+400
| +26% | +$7.2K |
|
2135
Jerash Holdings
JRSH
$63.5M
| $34K | ﹤0.01% |
+4,685
| New | +$32K |
|
2136
Ooma
OOMA
$604M
| $34K | ﹤0.01% |
2,589
-21,595
| -89% | -$325K |
|
2137
Rhinebeck Bancorp
RBKB
$194M
| $34K | ﹤0.01% |
+2,860
| New | +$33.6K |
|
|
BCOW
2138
DELISTED
1895 Bancorp of Wisconsin
BCOW
| $34K | ﹤0.01% |
+4,553
| New | +$33.3K |
|
|
CXDC
2139
DELISTED
China XD Plastics Company Limited
CXDC
| $34K | ﹤0.01% |
13,827
| – | – |
|
|
MDR
2140
DELISTED
McDermott International
MDR
| $34K | ﹤0.01% |
4,600
| – | – |
|
2141
Alto Ingredients
ALTO
$340M
| $33K | ﹤0.01% |
33,521
-31,079
| -48% | -$36.5K |
|
2142
Celldex Therapeutics
CLDX
$3.27B
| $33K | ﹤0.01% |
6,690
| – | – |
|
2143
Friedman Industries
FRD
$317M
| $33K | ﹤0.01% |
4,272
-48
| -1% | -$372 |
|
2144
Fuel Tech
FTEK
$43.7M
| $33K | ﹤0.01% |
19,597
+3,668
| +23% | +$4.82K |
|
2145
IMAX
IMAX
$2.66B
| $33K | ﹤0.01% |
1,477
-10,826
| -88% | -$231K |
|
2146
Kewaunee Scientific
KEQU
$106M
| $33K | ﹤0.01% |
1,556
| – | – |
|
2147
Plumas Bancorp
PLBC
$429M
| $33K | ﹤0.01% |
1,461
-364
| -20% | -$8.77K |
|
|
ARRS
2148
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $33K | ﹤0.01% |
1,055
-19,158
| -95% | -$601K |
|
|
NAVG
2149
DELISTED
Navigators Group Inc
NAVG
| $33K | ﹤0.01% |
468
-5,479
| -92% | -$382K |
|
|
TSRI
2150
DELISTED
TSR Inc. New
TSRI
| $33K | ﹤0.01% |
6,065
-100
| -2% | -$524 |
|
Similar funds
GAM
PPF
Panagora Asset Management's Q1 2019 Portfolio in Review
As of Q1 2019, Panagora Asset Management held 2,706 positions worth $22.5B, up 4.7% from $21.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Panagora Asset Management withdrew a net $1.78B in Q1 2019, closing 182 positions and reducing 968 holdings. Its most notable exit was Athenahealth, Inc., an estimated $19.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Panagora Asset Management opened a new position in iShares MSCI Hong Kong ETF worth $46.3M.
- Panagora Asset Management's largest Q1 2019 buy was iShares MSCI Hong Kong ETF: 1,767,867 shares worth $46.3M.
- Panagora Asset Management added most to Thermo Fisher Scientific in Q1 2019, an estimated $136M increase.
- Panagora Asset Management's biggest Q1 2019 reduction was UnitedHealth, cutting an estimated $145M.
- Panagora Asset Management fully exited Athenahealth, Inc. in Q1 2019, selling an estimated $19.8M.
- Panagora Asset Management's ten largest holdings make up 18% of its $22.5B portfolio in Q1 2019.
- Panagora Asset Management opened 231 new positions and closed 182 in Q1 2019.
- Panagora Asset Management's portfolio value rose 4.7% quarter-over-quarter to $22.5B.
Based on Panagora Asset Management's 13F filing for Q1 2019, filed 15 May 2019.